Biodexa Pharmaceuticals (BDRX) Short Interest Ratio & Short Volume $1.10 -0.03 (-2.65%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Biodexa Pharmaceuticals Short Interest DataBiodexa Pharmaceuticals (BDRX) has a short interest of 366,900 shares, representing 1.01% of the float (the number of shares available for trading by the public). This marks a 93.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 854,845 shares to cover all short positions.Current Short Interest366,900 sharesPrevious Short Interest189,600 sharesChange Vs. Previous Month+93.51%Dollar Volume Sold Short$395.63 thousandShort Interest Ratio0.1 Days to CoverLast Record DateMay 31, 2025Outstanding Shares36,544,000 sharesShort Percent of Float1.01%Today's Trading Volume102,592 sharesAverage Trading Volume854,845 sharesToday's Volume Vs. Average12% Short Selling Biodexa Pharmaceuticals? Sign up to receive the latest short interest report for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBDRX Short Interest Over TimeBDRX Days to Cover Over TimeBDRX Percentage of Float Shorted Over Time Biodexa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025366,900 shares $395.63 thousand +93.5%1.0%0.1 $1.08 5/15/2025189,600 shares $246.48 thousand -16.8%0.5%0.1 $1.30 4/30/2025228,000 shares $332.88 thousand -21.4%N/A0.1 $1.46 4/15/2025290,200 shares $423.69 thousand +323.7%0.8%0.2 $1.46 3/31/202568,500 shares $90.42 thousand +10.3%0.2%0 $1.32 3/15/202562,100 shares $117.99 thousand +72.0%0.2%0 $1.90 2/28/202536,100 shares $120.21 thousand -23.2%0.1%0 $3.33 2/15/202547,000 shares $200.69 thousand +1,368.8%0.1%0.1 $4.27 1/31/20253,200 shares $14.11 thousand -50.8%N/A0 $4.41 1/15/20256,500 shares $27.79 thousand -37.5%N/A0 $4.28 Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202410,400 shares $42.12 thousand -62.6%N/A0 $4.05 12/15/202427,800 shares $116.76 thousand -46.5%N/A0.1 $4.20 11/30/202452,000 shares $292.24 thousand +225.0%N/A0.2 $5.62 11/15/202416,000 shares $57.92 thousand +15.9%N/A0.1 $3.62 10/31/202413,800 shares $84.87 thousand -50.2%N/A0.1 $6.15 10/15/202427,700 shares $138.78 thousand +108.3%N/A0.2 $5.01 9/30/202413,300 shares $3.75 thousand -83.7%N/A0.2 $0.28 9/15/202481,400 shares $33.54 thousand -5.2%N/A0.1 $0.41 8/31/202485,900 shares $47.25 thousand -17.7%N/A0.1 $0.55 8/15/2024104,400 shares $63.13 thousand +63.4%N/A0.1 $0.60 7/31/202463,900 shares $44.09 thousand -89.2%N/A0 $0.69 7/15/2024589,700 shares $572.01 thousand +318.5%N/A0.1 $0.97 6/30/2024140,900 shares $126.23 thousand -35.6%N/A0 $0.90 6/15/2024218,800 shares $214.64 thousand -34.6%N/A0 $0.98 5/31/2024334,700 shares $322.78 thousand +3.9%N/A0.1 $0.96 5/15/2024322,000 shares $363.86 thousand -84.4%N/A0.1 $1.13 4/30/20242,060,000 shares $3.11 million +986.5%N/A0.6 $1.51 4/15/2024189,600 shares $157.97 thousand +183.8%N/A0.1 $0.83 3/31/202466,800 shares $108.22 thousand -34.9%N/A0 $1.62 3/15/2024102,600 shares $120.04 thousand -32.3%N/A0.2 $1.17 2/29/2024151,600 shares $192.53 thousand -37.1%N/A0.3 $1.27 2/15/2024241,100 shares $383.35 thousand +414.1%N/A0.2 $1.59 1/31/202446,900 shares $75.51 thousand +3.3%N/A0.1 $1.61 1/15/202445,400 shares $91.25 thousand -46.7%N/A0.1 $2.01 12/31/202385,100 shares $228.07 thousand -51.8%N/A0.1 $2.68 12/15/2023176,500 shares $524.21 thousand -43.3%N/A0.3 $2.97 11/30/2023311,300 shares $1.13 million +3,044.4%N/A0.5 $3.62 11/15/20239,900 shares $25.34 thousand -5.7%N/A0 $2.56 10/31/202310,500 shares $39.69 thousand -61.5%N/A0 $3.78 10/15/202327,300 shares $132.13 thousand +875.0%N/A0.1 $4.84Trump’s true trade war strategy (Ad)The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.This is fast becoming the world’s most sought-after resource. 9/30/20232,800 shares $13.97 thousand -63.6%N/A0 $4.99 9/15/20237,700 shares $47.59 thousand -64.2%N/A0 $6.18 8/31/202321,500 shares $171.79 thousand -28.3%N/A0 $7.99 8/15/202330,000 shares $148.80 thousand -50.3%N/A0.1 $4.96 7/31/202360,300 shares $328.64 thousand -27.1%N/A0.1 $5.45 7/15/202382,700 shares $445.75 thousand +100.2%N/A0.3 $5.39 6/30/202341,300 shares $226.65 thousand -85.5%N/A0.3 $5.49 6/15/2023284,600 shares $22.14 thousand +156.2%N/A0.1 $0.08 5/31/2023111,100 shares $9.33 thousand -37.8%N/A0 $0.08 5/15/2023178,700 shares $40.48 thousand No ChangeN/A0.1 $0.23 3/15/202384,900 shares $118.86 thousand +41.7%N/A1.6 $1.40 2/28/202359,900 shares $31.15 thousand +0.5%N/A1.2 $0.52 2/15/202359,600 shares $37.55 thousand +111.4%N/A1.3 $0.63 1/31/202328,200 shares $19.74 thousand +18.0%N/A0.7 $0.70 1/15/202323,900 shares $15.54 thousand -38.2%N/A0.8 $0.65 12/30/202238,700 shares $38.12 thousand +26.9%N/A2 $0.99 12/15/202230,500 shares $24.40 thousand +254.7%N/A1.7 $0.80 11/30/20228,600 shares $13.67 thousand -1.2%N/A0.4 $1.59 11/15/20228,700 shares $13.89 thousand +6.1%N/A0.4 $1.60 10/31/20228,200 shares $15.91 thousand +310.0%N/A0.3 $1.94 10/15/20222,000 shares $3.85 thousand -39.4%N/A0.1 $1.92 9/30/20223,300 shares $6.14 thousand -61.6%N/A0.1 $1.86 9/15/20228,600 shares $28.64 thousand -74.2%N/A0.4 $3.33 8/31/202233,300 shares $24.64 thousand +69.0%N/A0.7 $0.74 8/15/202219,700 shares $14.68 thousand -63.3%N/A0.1 $0.75 7/31/202253,700 shares $35.17 thousand +47.9%N/A0.3 $0.65 7/15/202236,300 shares $26.14 thousand -44.8%N/A0.2 $0.72 6/30/202265,800 shares $35.53 thousand -24.2%N/A0.3 $0.54 6/15/202286,800 shares $44.94 thousand +617.4%N/A0.4 $0.52 5/31/202212,100 shares $7.58 thousand -28.8%N/A0.1 $0.63 5/15/202217,000 shares $8.92 thousand +794.7%N/A0.3 $0.52 4/30/20221,900 shares $1.24 thousand -93.7%N/A0 $0.65 4/15/202230,100 shares $25.89 thousand -28.8%N/A0.5 $0.86 3/31/202242,300 shares $37.22 thousand +6.0%N/A0.7 $0.88 3/15/202239,900 shares $32.95 thousand +17.0%N/A0.5 $0.83 2/28/202234,100 shares $33.45 thousand -55.3%N/A0.3 $0.98 2/15/202276,300 shares $76.07 thousand +149.4%N/A0.6 $1.00 1/31/202230,600 shares $30.91 thousand -42.8%N/A0.2 $1.01 1/15/202253,500 shares $60.46 thousand +59.7%N/A0.4 $1.13 12/31/202133,500 shares $35.18 thousand -83.7%N/A0.2 $1.05 12/15/2021205,800 shares $234.61 thousand +53.5%N/A1.6 $1.14 11/30/2021134,100 shares $195.79 thousand +9.2%N/A1.4 $1.46 11/15/2021122,800 shares $200.16 thousand -31.3%N/A1.2 $1.63 10/29/2021178,700 shares $303.79 thousand +19.1%N/A1.8 $1.70 10/15/2021150,000 shares $255.75 thousand +1.6%N/A1.4 $1.71 9/30/2021147,600 shares $256.82 thousand -12.4%N/A1.2 $1.74 9/15/2021168,500 shares $291.51 thousand +1.9%N/A1.1 $1.73 8/31/2021165,400 shares $302.68 thousand -34.0%N/A0.1 $1.83 8/13/2021250,600 shares $455.32 thousand -9.4%N/A0.1 $1.82 7/30/2021276,700 shares $514.66 thousand +0.8%N/A0.1 $1.86Trump’s true trade war strategy (Ad)The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.This is fast becoming the world’s most sought-after resource. 7/15/2021274,600 shares $503.89 thousand -18.0%N/A0.1 $1.84 6/30/2021334,700 shares $696.18 thousand +102.2%N/A0.2 $2.08 6/15/2021165,500 shares $331 thousand No ChangeN/A0.1 $2.00 5/28/2021165,500 shares $316.11 thousand -7.9%N/A0.7 $1.91 5/14/2021179,700 shares $359.40 thousand +10.5%N/A0.6 $2.00 4/30/2021162,600 shares $320.32 thousand +7.4%N/A0.4 $1.97 4/15/2021151,400 shares $307.34 thousand -15.7%N/A0.2 $2.03 3/31/2021179,500 shares $384.13 thousand +7.1%N/A0.2 $2.14 3/15/2021167,600 shares $398.89 thousand -13.8%N/A0.2 $2.38 2/26/2021194,400 shares $480.17 thousand -5.6%N/A0.2 $2.47 2/12/2021206,000 shares $585.04 thousand +89.3%N/A0.2 $2.84 1/29/2021108,800 shares $233.92 thousand +1.2%N/A0.1 $2.15 1/15/2021107,500 shares $245.10 thousand -36.1%N/A0.3 $2.28 12/31/2020168,200 shares $319.58 thousand +43.5%N/A0.4 $1.90 12/15/2020117,200 shares $227.50 thousand +2.5%N/A0.3 $1.94 11/30/2020114,400 shares $208.21 thousand -16.3%N/A0.3 $1.82 11/15/2020136,600 shares $260.91 thousand -12.1%N/A0.4 $1.91 10/30/2020155,400 shares $289.04 thousand +50.0%N/A0 $1.86 10/15/2020103,600 shares $198.91 thousand -3.6%N/A0 $1.92 9/30/2020107,500 shares $194.58 thousand -7.7%N/A0 $1.81 9/15/2020116,500 shares $228.34 thousand -48.7%N/A0 $1.96 8/31/2020227,100 shares $526.87 thousand +4,731.9%N/A0 $2.32 8/14/20204,700 shares $12.78 thousand -99.6%N/A0 $2.72 7/31/20201,120,000 shares $2.28 million +5,585.3%N/A0.3 $2.04 7/15/202019,700 shares $25.41 thousand +146.3%N/A0 $1.29 6/30/20208,000 shares $11.12 thousand -73.6%N/A0 $1.39 6/15/202030,300 shares $42.12 thousand +83.6%N/A0.1 $1.39 BDRX Short Interest - Frequently Asked Questions What is Biodexa Pharmaceuticals' current short interest? Short interest is the volume of Biodexa Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 366,900 shares of BDRX short. 1.01% of Biodexa Pharmaceuticals' shares are currently sold short. Learn More on Biodexa Pharmaceuticals' current short interest. What is a good short interest percentage for Biodexa Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.01% of Biodexa Pharmaceuticals' floating shares are currently sold short. Is Biodexa Pharmaceuticals' short interest increasing or decreasing? Biodexa Pharmaceuticals saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 366,900 shares, an increase of 93.5% from the previous total of 189,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Biodexa Pharmaceuticals' short interest compare to its competitors? 1.01% of Biodexa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Biodexa Pharmaceuticals: Journey Medical Co. (4.40%), Tiziana Life Sciences Ltd (1.04%), Sagimet Biosciences Inc. (15.50%), Editas Medicine, Inc. (11.11%), Aclaris Therapeutics, Inc. (7.03%), Enanta Pharmaceuticals, Inc. (13.70%), Silence Therapeutics plc (3.51%), RAPT Therapeutics, Inc. (18.41%), LifeVantage Co. (19.68%), Molecular Partners AG (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Biodexa Pharmaceuticals stock? Short selling BDRX is an investing strategy that aims to generate trading profit from Biodexa Pharmaceuticals as its price is falling. BDRX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biodexa Pharmaceuticals? A short squeeze for Biodexa Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BDRX, which in turn drives the price of the stock up even further. How often is Biodexa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDRX, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Journey Medical Short Interest Data Tiziana Life Sciences Short Interest Data Sagimet Biosciences Short Interest Data Editas Medicine Short Interest Data Aclaris Therapeutics Short Interest Data Enanta Pharmaceuticals Short Interest Data Silence Therapeutics Short Interest Data RAPT Therapeutics Short Interest Data LifeVantage Short Interest Data Molecular Partners Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BDRX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BDRX Stock Free BDRX Stock Alerts